{"id":14557,"date":"2017-06-20T16:11:04","date_gmt":"2017-06-20T15:11:04","guid":{"rendered":"https:\/\/nationalwire.com.ng\/?p=14557"},"modified":"2017-06-20T16:11:04","modified_gmt":"2017-06-20T15:11:04","slug":"at-last-a-vaccine-to-fight-cholesterol","status":"publish","type":"post","link":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/","title":{"rendered":"At last, a vaccine to fight cholesterol"},"content":{"rendered":"<p>A cholesterol-lowering vaccine has successfully prevented heart disease in mice \u2014 and humans could be next.<\/p>\n<p>Known as AT04A, the vaccine triggers the production of antibodies that target an enzyme involved in regulating levels of blood cholesterol.<\/p>\n<p>When injected into mice, the vaccine treatment cut their total blood cholesterol by 53% over 12 months and also protected against the build-up of fatty deposits in the arteries.<\/p>\n<p>Researchers at the Medical University of Vienna have now started\u00a0the process of testing the vaccine on 72 human volunteers.<\/p>\n<p>According to the researchers, the first phase of human trials should be completed by the end of the year.<\/p>\n<p>Afterwards, they will check for possible\u00a0side-effects before commencing more studies in people.<\/p><div data-ad-id=\"32665\" style=\"text-align:center; margin-top:0px; margin-bottom:0px; margin-left:0px; margin-right:0px;float:none;\" class=\"afw afw_ad_image afw_ad afwadid-32665  \">\r\n                                                            <div style=\"font-size:10px;text-align:center;color:#cccccc;\">Advertisement<\/div>\r\n\t\t\t\t\t\t\t<a target=\"_blank\" href=\"http:\/\/www.accessbankplc.com\" rel=\"nofollow\"><img decoding=\"async\" height=\"auto\" max-width=\"100%\" src=\"https:\/\/nationalwire.com.ng\/wp-content\/uploads\/2019\/06\/Banner-1.jpg\"><\/a>\r\n                                                                        \r\n\t\t\t\t\t\t\t<\/div>\n<p>Gunther Staffler, chief technology officer at the Austrian biotech company AFFiRis, which developed the vaccine, said: \u201cAT04A was able to induce antibodies that specifically targeted the enzyme PCSK9 throughout the study period in the circulation of the treated mice.<\/p>\n<p>\u201cAs a consequence, levels of cholesterol were reduced in a consistent and long-lasting way, resulting in a reduction of fatty deposits in the arteries and atherosclerotic damage, as well as reduced arterial wall inflammation.<\/p>\n<p>\u201cIf these findings translate successfully into humans, this could mean that, as the induced antibodies persist for months after a vaccination, we could develop a long-lasting therapy that, after the first vaccination, just needs an annual booster. This would result in an effective and more convenient treatment for patients, as well as higher patient compliance.\u201d<\/p>\n<p>The findings were published in the European Heart Journal.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>A cholesterol-lowering vaccine has successfully prevented heart disease in mice \u2014 and humans could be next. Known as AT04A, the vaccine triggers the production of antibodies that target an enzyme involved in regulating levels of blood cholesterol. When injected into mice, the vaccine treatment cut their total blood cholesterol by 53% over 12 months and &hellip;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":11,"featured_media":14558,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[17],"tags":[2045],"coauthors":[2392,2393],"class_list":["post-14557","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-news","tag-cholesterol"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>At last, a vaccine to fight cholesterol - National Wire<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"At last, a vaccine to fight cholesterol - National Wire\" \/>\n<meta property=\"og:description\" content=\"A cholesterol-lowering vaccine has successfully prevented heart disease in mice \u2014 and humans could be next. Known as AT04A, the vaccine triggers the production of antibodies that target an enzyme involved in regulating levels of blood cholesterol. When injected into mice, the vaccine treatment cut their total blood cholesterol by 53% over 12 months and &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/\" \/>\n<meta property=\"og:site_name\" content=\"National Wire\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-20T15:11:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2017\/06\/vaccine.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"426\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dayo Emmanuel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#website\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/\",\"name\":\"National Wire\",\"description\":\"About Nigerians, Nigerian Business and Other Stories\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nationalwire.com.ng\/sub\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#primaryimage\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2017\/06\/vaccine.jpg\",\"contentUrl\":\"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2017\/06\/vaccine.jpg\",\"width\":640,\"height\":426},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#webpage\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/\",\"name\":\"At last, a vaccine to fight cholesterol - National Wire\",\"isPartOf\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#primaryimage\"},\"datePublished\":\"2017-06-20T15:11:04+00:00\",\"dateModified\":\"2017-06-20T15:11:04+00:00\",\"author\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/806673c5851717dc3067b1a46a6c060f\"},\"breadcrumb\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/nationalwire.com.ng\/sub\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"At last, a vaccine to fight cholesterol\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/806673c5851717dc3067b1a46a6c060f\",\"name\":\"Dayo Emmanuel\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/author\/dayo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"At last, a vaccine to fight cholesterol - National Wire","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/","og_locale":"en_US","og_type":"article","og_title":"At last, a vaccine to fight cholesterol - National Wire","og_description":"A cholesterol-lowering vaccine has successfully prevented heart disease in mice \u2014 and humans could be next. Known as AT04A, the vaccine triggers the production of antibodies that target an enzyme involved in regulating levels of blood cholesterol. When injected into mice, the vaccine treatment cut their total blood cholesterol by 53% over 12 months and &hellip;","og_url":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/","og_site_name":"National Wire","article_published_time":"2017-06-20T15:11:04+00:00","og_image":[{"width":640,"height":426,"url":"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2017\/06\/vaccine.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dayo Emmanuel","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/nationalwire.com.ng\/sub\/#website","url":"https:\/\/nationalwire.com.ng\/sub\/","name":"National Wire","description":"About Nigerians, Nigerian Business and Other Stories","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nationalwire.com.ng\/sub\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#primaryimage","url":"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2017\/06\/vaccine.jpg","contentUrl":"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2017\/06\/vaccine.jpg","width":640,"height":426},{"@type":"WebPage","@id":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#webpage","url":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/","name":"At last, a vaccine to fight cholesterol - National Wire","isPartOf":{"@id":"https:\/\/nationalwire.com.ng\/sub\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#primaryimage"},"datePublished":"2017-06-20T15:11:04+00:00","dateModified":"2017-06-20T15:11:04+00:00","author":{"@id":"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/806673c5851717dc3067b1a46a6c060f"},"breadcrumb":{"@id":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nationalwire.com.ng\/sub\/at-last-a-vaccine-to-fight-cholesterol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nationalwire.com.ng\/sub\/"},{"@type":"ListItem","position":2,"name":"At last, a vaccine to fight cholesterol"}]},{"@type":"Person","@id":"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/806673c5851717dc3067b1a46a6c060f","name":"Dayo Emmanuel","url":"https:\/\/nationalwire.com.ng\/sub\/author\/dayo\/"}]}},"_links":{"self":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts\/14557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/comments?post=14557"}],"version-history":[{"count":1,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts\/14557\/revisions"}],"predecessor-version":[{"id":14559,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts\/14557\/revisions\/14559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/media\/14558"}],"wp:attachment":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/media?parent=14557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/categories?post=14557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/tags?post=14557"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/coauthors?post=14557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}